TY  - JOUR
AU  - Cabello, Irene
AU  - Alia, Pedro
AU  - Pintó, Xavier
AU  - Muniesa, Cristina
AU  - Fernandez-de-Misa, Ricardo
AU  - Peñate, Yerai
AU  - Morillo, Mercedes
AU  - Perez-Farriols, Amparo
AU  - Estrach, Teresa
AU  - Izu, Rosa
AU  - Gallardo, Fernando
AU  - Román, Concepción
AU  - Cervigón, Iván
AU  - Ortiz-Brugues, Ariadna
AU  - Ortiz-Romero, Pablo L
AU  - Servitje, Octavio
PY  - 2018
DO  - 10.1001/jamadermatol.2018.3679
UR  - http://hdl.handle.net/10668/13177
T2  - JAMA dermatology
AB  - Hypertriglyceridemia is the most frequent and limiting adverse effect of bexarotene therapy in cutaneous T-cell lymphoma (CTCL). Despite standard prophylactic measures, there is a wide variability in the severity of this complication, which could be...
LA  - en
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - Apolipoprotein A-V
KW  - Apolipoprotein C-III
KW  - Bexarotene
KW  - DNA
KW  - Female
KW  - Follow-Up Studies
KW  - Genotype
KW  - Humans
KW  - Hypertriglyceridemia
KW  - Lymphoma, T-Cell, Cutaneous
KW  - Male
KW  - Middle Aged
KW  - Polymorphism, Genetic
KW  - Retrospective Studies
KW  - Severity of Illness Index
TI  - Association of APOA5 and APOC3 Genetic Polymorphisms With Severity of Hypertriglyceridemia in Patients With Cutaneous T-Cell Lymphoma Treated With Bexarotene.
TY  - research article
VL  - 154
ER  -